Literature DB >> 11039677

No increased risk of thrombosis in heterozygous congenital dysplasminogenemia.

T Shigekiyo1, M Kanazuka, K Aihara, H Azuma, Y Ohshima, H Horie, H Nakahira, T Takeichi, T Matsumoto.   

Abstract

To assess the risk of thrombosis in congenital dysplasminogenemia, we studied 10 unrelated families with this disorder. The probands were excluded from the analysis of data to prevent bias in the selection of subjects. Positive thrombotic histories were found in 1 of the 25 family members determined to have heterozygous congenital dysplasminogenemia and in 2 of their 41 biochemically unaffected relatives. The percentages of family members with no history of thrombosis up to a given age among subjects with and without congenital dysplasminogenemia were analyzed by the Kaplan-Meier method. No significant difference between the 2 groups was observed by generalized Wilcoxon test (P = .32) or Cox-Mantel test (P = .62). These findings suggest that heterozygous congenital dysplasminogenemia is not associated with an increased risk of thrombosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039677

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  1 in total

1.  A case of acute pulmonary embolism associated with dysplasminogenemia.

Authors:  Hongseok Yoo; Hee-Jin Kim; Chin A Yi; Yoon Young Cho; Ji Young Joung; Hyemin Jeong; Kyeongman Jeon
Journal:  J Korean Med Sci       Date:  2013-06-03       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.